N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Request For Quotation
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Suppliers list
Company Name: ANHUI WITOP BIOTECH CO., LTD  
Tel: +8618071025641
Email: eric@witopchemical.com
Company Name: Beijing xinyanhui pharmaceutical research and development co., LTD  
Tel: 13969155946
Email: 1461866103@qq.com
Company Name: Nanjing wangzhixing Pharmaceutical Technology Co., Ltd  
Tel: 18569809817
Email: 2208093734@qq.com
Company Name: Suzhou Meishi Biotechnology Co., Ltd.  
Tel: 1173954148q
Email: meishipharma@126.com
Company Name: Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd  
Tel: 020-18102736 13622807357
Email: Zark@zlstandards.com
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Basic information
Product Name:N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Synonyms:N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[4-methyl-1-(phenylmethyl)-3-piperidinyl]-
CAS:384337-90-0
MF:C20H25N5
MW:335.45
EINECS:
Product Categories:
Mol File:384337-90-0.mol
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Structure
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Chemical Properties
density 1.205±0.06 g/cm3(Predicted)
pka13.36±0.50(Predicted)
Safety Information
MSDS Information
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Usage And Synthesis
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Preparation Products And Raw materials
Preparation ProductsN-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tag:N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine(384337-90-0) Related Product Information
4-Amino-2,6-dichloropyrimidine 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride 2-Chloro-3,7-dihydro-4H-pyrrolo[2,3-d]pyriMidin-4-one Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-7-[(4-methylphenyl)sulfonyl]-N-[(3R,4R)-4-methyl-3-piperidinyl]- Tofacitinib Impurity 29 Tofacitinib Impurity 2 (1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine N-[[(2-Methyl-5-nitrophenyl)amino]thioxomethyl]acetamide Trametinib N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(phenylsulfonyl)-4-quinazolinaMine N-(3-(2-bromo-2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Tofacitinib Impurity 85